DE69534283D1 - Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe - Google Patents
Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabeInfo
- Publication number
- DE69534283D1 DE69534283D1 DE69534283T DE69534283T DE69534283D1 DE 69534283 D1 DE69534283 D1 DE 69534283D1 DE 69534283 T DE69534283 T DE 69534283T DE 69534283 T DE69534283 T DE 69534283T DE 69534283 D1 DE69534283 D1 DE 69534283D1
- Authority
- DE
- Germany
- Prior art keywords
- clonic
- active ingredients
- medicinal product
- containing medicinal
- delayed active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/136,309 US5484607A (en) | 1993-10-13 | 1993-10-13 | Extended release clonidine formulation |
PCT/US1995/001029 WO1996022768A1 (en) | 1993-10-13 | 1995-01-26 | Extended release clonidine formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69534283D1 true DE69534283D1 (de) | 2005-07-21 |
DE69534283T2 DE69534283T2 (de) | 2006-03-16 |
Family
ID=26789483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69534283T Expired - Lifetime DE69534283T2 (de) | 1993-10-13 | 1995-01-26 | Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0805677B1 (de) |
AU (1) | AU707843B2 (de) |
CA (1) | CA2211325C (de) |
DE (1) | DE69534283T2 (de) |
ES (1) | ES2245782T3 (de) |
WO (1) | WO1996022768A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2637292A1 (en) * | 2006-01-27 | 2007-08-16 | F. Hoffmann-La Roche Ag | Use of 2-imidazoles for the treatment of cns disorders |
ES2381589T3 (es) | 2006-10-19 | 2012-05-29 | F. Hoffmann-La Roche Ag | Aminometil-4-imidazoles |
ATE533755T1 (de) | 2006-11-02 | 2011-12-15 | Hoffmann La Roche | Substituierte 2-imidazole als modulatoren der mit spurenaminen assoziierten rezeptoren |
CA2669112A1 (en) | 2006-11-16 | 2008-05-22 | F. Hoffmann-La Roche Ag | Substituted 4-imidazoles |
MX2009005920A (es) | 2006-12-13 | 2009-06-16 | Hoffmann La Roche | Nuevos 2-imidazoles como ligandos para receptores asociados con trazas de amina. |
US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
BRPI0806940A2 (pt) | 2007-02-02 | 2014-05-06 | Hoffmann La Roche | 2-amino-oxazolinas como ligantes taar1 para distúrbios do snc |
BRPI0807813A2 (pt) | 2007-02-15 | 2014-08-05 | Hoffmann La Roche | 2-amino-oxazolinas como ligantes de taar1 |
KR20100020459A (ko) * | 2007-06-08 | 2010-02-22 | 아드레넥스 파마슈티컬스, 아이엔씨. | 지연 방출형 제제 및 아드레날린 조절부전의 치료방법 |
WO2009003868A2 (en) | 2007-07-02 | 2009-01-08 | F. Hoffmann-La Roche Ag | 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
WO2009003867A1 (en) | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
WO2009016048A1 (en) | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
AU2008285795A1 (en) | 2007-08-03 | 2009-02-12 | F. Hoffmann-La Roche Ag | Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands |
EP2090307A1 (de) * | 2008-02-15 | 2009-08-19 | Bone Therapeutics | Pharmazeutische Zusammensetzung zur Behandlung oder Verhinderung von Knochengelenkserkrankungen |
US8242153B2 (en) | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
CN104352473A (zh) * | 2014-11-21 | 2015-02-18 | 哈尔滨圣吉药业股份有限公司 | 一种盐酸可乐定缓释片及其制备方法 |
WO2017157873A1 (en) | 2016-03-17 | 2017-09-21 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6248618A (ja) * | 1985-08-27 | 1987-03-03 | Zeria Shinyaku Kogyo Kk | 徐放性製剤およびその製造法 |
JPS62145014A (ja) * | 1985-12-18 | 1987-06-29 | Teijin Ltd | 活性持続型医薬品製剤 |
US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
-
1995
- 1995-01-26 EP EP95944804A patent/EP0805677B1/de not_active Expired - Lifetime
- 1995-01-26 DE DE69534283T patent/DE69534283T2/de not_active Expired - Lifetime
- 1995-01-26 CA CA002211325A patent/CA2211325C/en not_active Expired - Lifetime
- 1995-01-26 ES ES95944804T patent/ES2245782T3/es not_active Expired - Lifetime
- 1995-01-26 AU AU52593/96A patent/AU707843B2/en not_active Expired
- 1995-01-26 WO PCT/US1995/001029 patent/WO1996022768A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2211325A1 (en) | 1996-08-01 |
AU5259396A (en) | 1996-08-14 |
EP0805677B1 (de) | 2005-06-15 |
AU707843B2 (en) | 1999-07-22 |
ES2245782T3 (es) | 2006-01-16 |
CA2211325C (en) | 2006-08-15 |
EP0805677A1 (de) | 1997-11-12 |
WO1996022768A1 (en) | 1996-08-01 |
DE69534283T2 (de) | 2006-03-16 |
EP0805677A4 (de) | 1998-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69922964D1 (de) | Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe | |
ATE201989T1 (de) | Arzneimittel mit kontrollierter wirkstoffabgabe | |
DE69534283D1 (de) | Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe | |
DE69723303D1 (de) | Arzneimittel mit verzögerter wirkstoffabgabe | |
DE69003568D1 (de) | Arzneimittel mit verzoegerter freigabe. | |
ATE163539T1 (de) | Arzneimittel | |
HUP9601566A3 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
BR1100329A (pt) | Composto e formulação farmacêutica | |
ATE248594T1 (de) | Irbesartanhaltiges arzneimittel | |
DE3782840D1 (de) | Arzneimittel mit verzoegerter freigabe. | |
BR1100824A (pt) | Composto e composição farmacêutica | |
DE3786481D1 (de) | Topische antimikrobielle arzneimittel. | |
MX9202839A (es) | 4-aminoquinolinas y composiciones farmaceuticas de las mismas. | |
EP0645136A3 (de) | Pharmazeutisches Präparat des Typs: physiologisch aktive Substanz mit verlängerter Freisetzung. | |
NO943888D0 (no) | Farmasöytisk preparat | |
GB2271059B (en) | Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives. | |
DE68908354D1 (de) | Verpackung fuer arzneimittel. | |
DE69937891D1 (de) | Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe | |
DE69813602D1 (de) | Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe | |
DE69430580D1 (de) | Arzneimittel in nahrungsmittelform | |
EE03015B1 (et) | Ravimpreparaat ja selle valmistamise protsess | |
GB9504040D0 (en) | Arylsulfonamide derivative and pharmaceutical composition containing the same | |
DE69214310D1 (de) | Pranoprofen enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe | |
LV10365A (lv) | Cepumi ar augstu graudu saturu | |
DE68907392D1 (de) | Dysmnesie modifizierende arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |